Aileron Therapeutics (NASDAQ:ALRN – Get Rating) and Agios Pharmaceuticals (NASDAQ:AGIO – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, earnings, institutional ownership, risk, dividends and valuation. Analyst Ratings This is a summary of current ratings […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Rating) has earned an average recommendation of “Buy” from the eight ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month target price among […]
Zacks Investment Research lowered shares of Stoke Therapeutics (NASDAQ:STOK – Get Rating) from a buy rating to a hold rating in a report published on Wednesday morning, Zacks.com reports. According to Zacks, “Stoke Therapeutics Inc. is a biopharmaceutical company. It develops antisense oligonucleotide medicines to treat genetic diseases. The company’s product candidate consists of STK-001 […]